MyBiotics Signs Second Option to License Agreement with Ferring Holding for Microbiome-Based Therapies
Mar 05, 2018 – MyBiotics Pharma announced today that it has entered into a second option agreement with Ferring Holding Ltd. for the validation of MyBiotics’ microbiome-based therapeutics in the field of women’s health. This agreement follows the first agreement between the two parties signed in June 2017, for the validation of MyBiotics’ technology in the treatment of a non-disclosed gastroenterology condition.
